Exploration Capital, LLC - 03 Apr 2024 Form 4 Insider Report for Fresh Tracks Therapeutics, Inc.

Role
10%+ Owner
Signature
Stephen L. Gustin on behalf of Exploration Capital, LLC
Issuer symbol
N/A
Transactions as of
03 Apr 2024
Net transactions value
+$15,814
Form type
4
Filing time
05 Apr 2024, 17:18:51 UTC
Previous filing
01 Apr 2024
Next filing
11 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FRTX Common Stock Purchase $11,764 +12,928 +1.3% $0.9100 1,031,641 03 Apr 2024 Direct F1, F2
transaction FRTX Common Stock Purchase $3,094 +3,400 +0.33% $0.9100 1,035,041 04 Apr 2024 Direct F1, F2
transaction FRTX Common Stock Purchase $956 +1,050 +0.1% $0.9100 1,036,091 05 Apr 2024 Direct F1, F2
holding FRTX Common Stock 47,000 03 Apr 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exploration Capital, LLC ("X-Cap") is the investment manager of Exploration Capital Fund, LP (the "Partnership") and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Exploration Capital General Partner, LLC (the "GP") is the general partner of the Partnership and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership.
F2 Stephen L. Gustin is the Managing Partner of X-Cap and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Mr. Gustin disclaims beneficial ownership of the reported securities held by the Partnership except to the extent of his pecuniary interest.
F3 These shares are directly owned by Stephen L. Gustin.